Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
  2. Basudhar, Debashree; Miranda, Katrina M.; Wink, David; Ridnour, Lisa
  3. REDOX-ACTIVE THERAPEUTICS. 2016; : 377-403.
  1. 2.   Profiling of cell cycle genes of breast cells exposed to etodolac
  2. Roy, D.; Arason, G. A.; Chowdhury, B.; Mitra, A.; Calaf, G. M.
  3. Oncology Reports. 2010, May; 23(5): 1383-1391.
  1. 3.   PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
  2. Dossus, L.; Kaaks, R.; Canzian, F.; Albanes, D.; Berndt, S. I.; Boeing, H.; Buring, J.; Chanock, S. J.; Clavel-Chapelon, F.; Feigelson, H. S.; Gaziano, J. M.; Giovannucci, E.; Gonzalez, C.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hayes, R. B.; Henderson, B. E.; Hoover, R. N.; Hunter, D. J.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Ma, J.; Le Marchand, L.; Lund, E.; Peeters, P. H. M.; Stampfer, M.; Stram, D. O.; Thomas, G.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Riboli, E.; Virtamo, J.; Weinstein, S. J.; Yeager, M.; Ziegler, R. G.; Cox, D. G.
  3. Carcinogenesis. 2010, Mar; 31(3): 455-461.
  1. 4.   Nuclear Accumulation of beta-Catenin Protein Indicates Activation of wnt Signaling in Chemically Induced Rat Nephroblastomas
  2. Ehrlich, D.; Bruder, E.; Thome, M. A.; Gutt, C. N.; Doeberitz, M. V.; Niggli, F.; Perantoni, A. O.; Koesters, R.
  3. Pediatric and Developmental Pathology. 2010, Jan-Feb; 13(1): 1-8.
  1. 5.   Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence-Data from a Randomized Clinical Trial
  2. Barry, E. L.; Sansbury, L. B.; Grau, M. V.; Ali, I. U.; Tsang, S.; Munroe, D. J.; Ahnen, D. J.; Sandler, R. S.; Saibil, F.; Gui, J.; Bresalier, R. S.; McKeown-Eyssen, G. E.; Burke, C.; Baron, J. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(10): 2726-2733.
  1. 6.   Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation
  2. MacDonald, C. J.; Cheng, R.; Roberts, D. D.; Wink, D. A.; Yeh, G. C.
  3. Journal of Biological Chemistry. 2009 284(33): 22099-22107.
  1. 7.   Second-generation aspirin and indomethacin prodrugs possessing an O-2-(Acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation, and nitric oxide release studies
  2. Velazquez, C. A.; Chen, Q. H.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Journal of Medicinal Chemistry. 2008 51(6): 1954-1961.
  1. 8.   Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer
  2. Daugherty, S. E.; Shugart, Y. Y.; Platz, E. A.; Fallin, M. D.; Isaacs, W. B.; Pfeiffer, R. M.; Welch, R.; Huang, W. Y.; Reding, D.; Hayes, R. B.
  3. Prostate. 2007, Oct; 67(14): 1487-1497.
  1. 9.   Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma
  2. Daugherty, S. E.; Platz, E. A.; Shugart, Y. Y.; Fallin, M. D.; Isaacs, W. B.; Chatterjee, N.; Welch, R.; Huang, W. Y.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Aug; 16(8): 1536-1542.
  1. 10.   O-2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies
  2. Velazquez, C. A.; Rao, P. N. P.; Citro, M. L.; Keefer, L. K.; Knaus, E. E.
  3. Bioorganic & Medicinal Chemistry. 2007, Jul; 15(14): 4767-4774.
  1. 11.   AP-1 a target for cancer prevention
  2. Matthews, C. P.; Colburn, N. H.; Young, M. R.
  3. Current Cancer Drug Targets. 2007, Jun; 7(4): 317-324.
  1. 12.   Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid
  2. Isenberg, J. S.; Jia, Y.; Field, L.; Ridnour, L. A.; Sparatore, A.; Del Soldato, P.; Sowers, A. L.; Yeh, G. C.; Moody, T. W.; Wink, D. A.; Ramchandran, R.; Roberts, D. D.
  3. British Journal of Pharmacology. 2007, May; 151(1): 142-151.
  1. 13.   Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro
  2. Ciolino, H. P.; MacDonald, C. J.; Memon, O. S.; Bass, S. E.; Yeh, G. C.
  3. Carcinogenesis. 2006, Aug; 27(8): 1586-1592.
  1. 14.   Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
  2. Ali, I. U.; Luke, B. T.; Dean, M.; Greenwald, P.
  3. British Journal of Cancer. 2005, OCT 17; 93(8): 953-959.
  1. 15.   Suboptimal prescribing in elderly outpatients: Potentially harmful drug-drug and drug-disease combinations
  2. Zhan, C. L.; Correa-de-Araujo, R.; Bierman, A. S.; Sangl, J.; Miller, M. R.; Wickizer, S. W.; Stryer, D.
  3. Journal of the American Geriatrics Society. 2005, FEB; 53(2): 262-267.
  1. 16.   Reactive oxygen species and lung tumorigenesis by mutant K-ras: A working hypothesis
  2. Maciag, A.; Anderson, L. M.
  3. Experimental Lung Research. 2005, JAN-FEB; 31(1): 83-104.
  1. 17.   Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents
  2. Zhu, J. X.; Song, X. Q.; Lin, H. P.; Young, D. C.; Yan, S. Q.; Marquez, V. E.; Chen, C. S.
  3. Journal of the National Cancer Institute. 2002 94(23): 1745-1757.
  1. 18.   PPAR and immune system - what do we know?
  2. Zhang, X.; Young, H. A.
  3. International Immunopharmacology. 2002 2(8): 1029-1044.
  1. 19.   Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice
  2. Arbeit, J. M.; Riley, R. R.; Huey, B.; Porter, C.; Kelloff, G.; Lubet, R.; Ward, J. M.; Pinkel, D.
  3. Cancer Research. 1999 59(15): 3610-3620.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel